Welcome to the Wharton Club of Northern California - Wharton Healthcare Alumni at JPMorgan!

   New user, registration is FREE Sign In  


Wharton Healthcare Alumni at JPMorgan!

Kick off the New Year by joining Fellow Wharton Healthcare Alumni and other Wharton alums at the 2015 JPMorgan Healthcare Conference in San Francisco.

 When: Wednesday, January 14, 2015

 Time: 8:30 pm - 11:30 pm PST

 What: Appetizers, Beer and Wine  

 Cost: Free to current WHCMAA and Wharton Club of Northern California members only

 Location:  620 Jones Street
San Francisco, CA

Attendees must register online to be admitted to the event.
 Registration closes Friday, January 9th at 5:00pm. Please register online by clicking here.

With special thanks to our sponsors:


For sponsorship opportunities to this event, please click here

Duane Morris LLP

Duane Morris LLP, a full-service law firm with more than 700 attorneys in offices across the United States and around the world, offers innovative solutions to the legal and business challenges presented by today's evolving global markets.

Growth and Culture

Evolving from a partnership of prominent lawyers in Philadelphia a century ago, Duane Morris now has offices in many major markets and continues to expand across the country and overseas. Throughout this expansion, Duane Morris remains committed to preserving the collegial culture that has attracted so many talented attorneys. The firm's leadership believes this culture is truly unique among large law firms, and that outstanding legal work is best accomplished by skilled professionals who respect each other and work well together.

Leadership and Experience

Duane Morris lawyers hold leadership positions in professional associations, as well as in educational, cultural and charitable organizations and with community groups. Many of the firm's attorneys come to Duane Morris after having held senior positions in government agencies and large corporations.

For more information, visit www.duanemorris.com.

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

For more information, visit www.celgene.com

Locust Walk Partners

Locust Walk Partners is a business development advisory firm that offers transaction, strategy, and commercial support to life sciences companies. Our team has extensive industry operating experience with senior-level professionals leading and executing all engagements.  We have led or participated in close to 40 transactions with an aggregate value exceeding $6B.  Our model is collaborative – we work closely with our Clients to leverage and expand their in-house capabilities.  Locust Walk Partners is well networked with decision-makers in leading life science companies and the investment community.  Our office is located in Cambridge, MA.

For more information visit www.locustwalkpartners.com. 

HealthCare Royalty Partners

HealthCare Royalty Partners is a $3.0+ billion global healthcare investment firm. We invest primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the world’s largest pharmaceutical companies. Over the past decade, our senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. 

For more information visit www.healthcareroyalty.com.

MDCR - Medical Device Consultants of Ridgewood, LLC

MDCR is a firm dedicated to ensuring appropriate coverage and payment policies for medical technology companies and insurers through healthcare analytics, cost-effectiveness analysis, & evidence assessments. 

For additional information on MDCR contact:  meddevconsultant@aol.com.

The Wharton Club of Northern California
© Copyright Wharton Club of Northern California, ALL RIGHTS RESERVED.

Alumni Development Software